Recurrent Non-small Cell Lung Cancer Completed Phase 2 Trials for Hydroxychloroquine (DB01611)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01649947Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase IITreatment